Pharmacological agents blocking Ang2 and norepinephrine (ARBs, ACE inhibitors, beta‐blockers, etc) have been used clinically for decades as treatment for established HFrEF; however, this approach still inevitably results in worsening and progression of HF leading to substantial morbidity and mortality worldwide. This evidence concerns the gene ACE and hydrops fetalis.